Clinical trial Recruiting at 1 site Observational Ages 18 and up

Deriving human embryonic stem cell lines from embryos tested for genetic abnormalities

Official title: The Derivation of Human Embryonic Stem Cell Lines From PGD Embryos

Run by Hadassah Medical Organization · NCT00353210 · Data updated 2026-11-12

This study is trying to create new human stem cell lines from embryos that were found to have genetic issues so that researchers can use them to learn more about diseases and develop new treatments.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorHadassah Medical Organization
Academic / other
Locations1 site (Jerusalem)
StatusRecruiting
StartedApril 6, 2004
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedMarch 5, 2025
Trial IDNCT00353210 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are couples who have undergone IVF and have embryos diagnosed as abnormal through PGD that they do not wish to use for family building.

Probably not a fit

Patients who do not have embryos available for donation or who are not undergoing IVF will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on isolating human embryonic stem cells (hESCs) from embryos that have been diagnosed as abnormal through preimplantation genetic diagnosis (PGD). The approach involves using embryos that would typically be discarded after IVF procedures, thereby providing an ethically viable source of hESCs for research. These stem cells have the potential to proliferate indefinitely and differentiate into various cell types, making them valuable for studying developmental biology and potential therapies for degenerative diseases. The research aims to create new hESC lines that can be shared with scientists globally for further investigation.

Why it matters

Potential benefit: If successful, this research could provide a significant resource for studying diseases and developing new treatments using human embryonic stem cells.

How similar studies have gone: Previous studies have successfully derived hESC lines from surplus embryos, indicating a promising approach for this research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Couple has derived embryos by IVF.
* Couple has tested these embryos by PGD and does not want to utilize the embryos to build their families.
* Couple signs informed consent.

Exclusion Criteria:

* Couple does not sign informed consent.

Where it's running

  • Hadassah Medical Organization
    Jerusalem, Israel
    Recruiting

Study contacts

  • Principal investigator: Benjamin E. Reubinoff, M.D. PhD. — Hadassah Medical Organization
  • Study coordinator: Benjamin E. Reubinoff, M.D. PhD.
  • Email: reubinof@md.huji.ac.il
  • Phone: 011-972-2-677-7111

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.